‘Liquid biopsy’ continues to show promise in prostate cancer

Study results add further support to the use of circulating tumor cells as an effective prognostic marker in prostate cancer, and suggest that they could be used to monitor metastatic disease progression.
Source: MedWire News - Urology - Category: Urology & Nephrology Source Type: news